Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study

Neurosurgery. 2006 Nov;59(5):E1152; author reply E1152. doi: 10.1227/01.NEU.0000249031.26372.13.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control*
  • Calcium Channel Blockers / administration & dosage*
  • Calcium Channel Blockers / therapeutic use
  • Cerebral Angiography
  • Cerebral Infarction / epidemiology
  • Cerebral Infarction / etiology
  • Cerebral Infarction / mortality
  • Female
  • Humans
  • Incidence
  • Injections, Intravenous
  • Intracranial Aneurysm / complications*
  • Magnesium / administration & dosage*
  • Magnesium / therapeutic use
  • Male
  • Middle Aged
  • Nimodipine / administration & dosage*
  • Nimodipine / therapeutic use
  • Pilot Projects
  • Subarachnoid Hemorrhage / drug therapy*
  • Subarachnoid Hemorrhage / etiology*
  • Treatment Outcome
  • Ultrasonography, Doppler, Transcranial
  • Vasospasm, Intracranial / complications
  • Vasospasm, Intracranial / diagnosis
  • Vasospasm, Intracranial / epidemiology
  • Vasospasm, Intracranial / etiology

Substances

  • Calcium Channel Blockers
  • Nimodipine
  • Magnesium